Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 46

1.

Pluripotency transcription factor Sox2 is strongly adsorbed by heparin but requires a protein transduction domain for cell internalization.

Albayrak C, Yang WC, Swartz JR.

Biochem Biophys Res Commun. 2013 Feb 15;431(3):641-5. doi: 10.1016/j.bbrc.2012.11.016. Epub 2013 Jan 11.

PMID:
23318174
2.

Phosphorylation of Sox2 cooperates in reprogramming to pluripotent stem cells.

Jeong CH, Cho YY, Kim MO, Kim SH, Cho EJ, Lee SY, Jeon YJ, Lee KY, Yao K, Keum YS, Bode AM, Dong Z.

Stem Cells. 2010 Dec;28(12):2141-50. doi: 10.1002/stem.540. Erratum in: Stem Cells. 2012 Sep;30(9):2064.

3.

Klf4 interacts directly with Oct4 and Sox2 to promote reprogramming.

Wei Z, Yang Y, Zhang P, Andrianakos R, Hasegawa K, Lyu J, Chen X, Bai G, Liu C, Pera M, Lu W.

Stem Cells. 2009 Dec;27(12):2969-78. doi: 10.1002/stem.231.

4.

Pluripotent reprogramming of fibroblasts by lentiviral mediated insertion of SOX2, C-MYC, and TCL-1A.

Picanço-Castro V, Russo-Carbolante E, Reis LC, Fraga AM, de Magalhães DA, Orellana MD, Panepucci RA, Pereira LV, Covas DT.

Stem Cells Dev. 2011 Jan;20(1):169-80. doi: 10.1089/scd.2009.0424. Epub 2010 Oct 29.

PMID:
20504151
5.

Optimal reprogramming factor stoichiometry increases colony numbers and affects molecular characteristics of murine induced pluripotent stem cells.

Tiemann U, Sgodda M, Warlich E, Ballmaier M, Schöler HR, Schambach A, Cantz T.

Cytometry A. 2011 Jun;79(6):426-35. doi: 10.1002/cyto.a.21072. Epub 2011 May 4.

6.

More synergetic cooperation of Yamanaka factors in induced pluripotent stem cells than in embryonic stem cells.

Huang J, Chen T, Liu X, Jiang J, Li J, Li D, Liu XS, Li W, Kang J, Pei G.

Cell Res. 2009 Oct;19(10):1127-38. doi: 10.1038/cr.2009.106. Epub 2009 Sep 8.

PMID:
19736564
7.

Heparin binding by the HIV-1 tat protein transduction domain.

Hakansson S, Jacobs A, Caffrey M.

Protein Sci. 2001 Oct;10(10):2138-9.

8.

Activation of pluripotency-associated genes in mouse embryonic fibroblasts by non-viral transfection with in vitro-derived mRNAs encoding Oct4, Sox2, Klf4 and cMyc.

Tavernier G, Wolfrum K, Demeester J, De Smedt SC, Adjaye J, Rejman J.

Biomaterials. 2012 Jan;33(2):412-7. doi: 10.1016/j.biomaterials.2011.09.062. Epub 2011 Oct 10.

PMID:
21993235
9.

Epithelial plasticity, stemness and pluripotency.

Ocaña OH, Nieto MA.

Cell Res. 2010 Oct;20(10):1086-8. doi: 10.1038/cr.2010.127. Epub 2010 Sep 7. No abstract available.

PMID:
20820188
10.

Cell-free production of transducible transcription factors for nuclear reprogramming.

Yang WC, Patel KG, Lee J, Ghebremariam YT, Wong HE, Cooke JP, Swartz JR.

Biotechnol Bioeng. 2009 Dec 15;104(6):1047-58. doi: 10.1002/bit.22517.

11.

Reprogramming of mouse and human somatic cells by high-performance engineered factors.

Wang Y, Chen J, Hu JL, Wei XX, Qin D, Gao J, Zhang L, Jiang J, Li JS, Liu J, Lai KY, Kuang X, Zhang J, Pei D, Xu GL.

EMBO Rep. 2011 Apr;12(4):373-8. doi: 10.1038/embor.2011.11. Epub 2011 Mar 11. Erratum in: EMBO Rep. 2011 May 1;12(5):478.

12.

[Induced pluripotent stem cells generated from reprogramming differentiated cells by defined factors].

Xia X, Chu J, Chen X.

Sheng Wu Gong Cheng Xue Bao. 2008 Jul;24(7):1121-7. Review. Chinese.

PMID:
18837383
13.

Reprogramming of neural progenitor cells into induced pluripotent stem cells in the absence of exogenous Sox2 expression.

Eminli S, Utikal J, Arnold K, Jaenisch R, Hochedlinger K.

Stem Cells. 2008 Oct;26(10):2467-74. doi: 10.1634/stemcells.2008-0317. Epub 2008 Jul 17.

14.

Two-factor reprogramming of somatic cells to pluripotent stem cells reveals partial functional redundancy of Sox2 and Klf4.

Nemajerova A, Kim SY, Petrenko O, Moll UM.

Cell Death Differ. 2012 Aug;19(8):1268-76. doi: 10.1038/cdd.2012.45. Epub 2012 Apr 27.

15.

Oct4-enhanced green fluorescent protein transgenic pigs: a new large animal model for reprogramming studies.

Nowak-Imialek M, Kues WA, Petersen B, Lucas-Hahn A, Herrmann D, Haridoss S, Oropeza M, Lemme E, Schöler HR, Carnwath JW, Niemann H.

Stem Cells Dev. 2011 Sep;20(9):1563-75. doi: 10.1089/scd.2010.0399. Epub 2011 Jan 12.

PMID:
21126163
16.

DNA-dependent Oct4-Sox2 interaction and diffusion properties characteristic of the pluripotent cell state revealed by fluorescence spectroscopy.

Lam CS, Mistri TK, Foo YH, Sudhaharan T, Gan HT, Rodda D, Lim LH, Chou C, Robson P, Wohland T, Ahmed S.

Biochem J. 2012 Nov 15;448(1):21-33. doi: 10.1042/BJ20120725.

PMID:
22909387
17.

Using small molecules to improve generation of induced pluripotent stem cells from somatic cells.

Desponts C, Ding S.

Methods Mol Biol. 2010;636:207-18. doi: 10.1007/978-1-60761-691-7_13.

PMID:
20336525
18.

Endogenous KLF4 expression in human fetal endothelial cells allows for reprogramming to pluripotency with just OCT3/4 and SOX2--brief report.

Ho PJ, Yen ML, Lin JD, Chen LS, Hu HI, Yeh CK, Peng CY, Lin CY, Yet SF, Yen BL.

Arterioscler Thromb Vasc Biol. 2010 Oct;30(10):1905-7. doi: 10.1161/ATVBAHA.110.206540. Epub 2010 Aug 5.

19.

Two-step generation of induced pluripotent stem cells from mouse fibroblasts using Id3 and Oct4.

Moon JH, Heo JS, Kwon S, Kim J, Hwang J, Kang PJ, Kim A, Kim HO, Whang KY, Yoon BS, You S.

J Mol Cell Biol. 2012 Feb;4(1):59-62. doi: 10.1093/jmcb/mjr038. Epub 2011 Nov 30. No abstract available.

PMID:
22131360
20.

Induction of pluripotent stem cells from primary human fibroblasts with only Oct4 and Sox2.

Huangfu D, Osafune K, Maehr R, Guo W, Eijkelenboom A, Chen S, Muhlestein W, Melton DA.

Nat Biotechnol. 2008 Nov;26(11):1269-75. doi: 10.1038/nbt.1502. Epub 2008 Oct 12.

PMID:
18849973

Supplemental Content

Support Center